ApideckTape
← Embedded Finance Index 2026

BioTrack

“Can a cannabis seed-to-sale compliance platform monetize the payments layer through cashless-ATM rails that work around federal card-network prohibitions?”

Founded2010
HQFort Lauderdale, Florida, United States
Total raised$5M
IndustryVertical SaaS / Cannabis
The story

BioTrack is a vertical SaaS company for the cannabis industry, founded 2010 in Fort Lauderdale. Its core product is seed-to-sale inventory tracking and a dispensary POS system, sold to both operators and state regulators as a traceability system. Its embedded-finance angle is narrow but strategic: because cannabis is federally illegal in the US, Visa/Mastercard rails are closed to dispensaries, so BioTrack layered a cashless ATM / point-of-banking solution ('BioTrack Pay') into the POS to displace cash-only operations. No banking, lending, payroll, or open-banking depth — the stack is deliberately shallow because the underlying rails are constrained.

Last 12 months
—
Product timeline
2010
BioTrack founded as pioneer of seed-to-sale tracking for cannabis business management and government oversight· pivot
2024
BioTrack Pay launched — integrated cashless payments (point-of-banking / cashless ATM) inside the POS· banking
The stack
1 layer disclosed in BioTrack’s embedded-finance stack
Payments / PSP
BioTrack Pay (self-operated)
Accounting gap: significant

BioTrack — frequently asked

Who is BioTrack's payment processor?

BioTrack processes payments through BioTrack Pay (self-operated).

Where is BioTrack headquartered?

BioTrack is founded in 2010 and headquartered in Fort Lauderdale, Florida, United States.

How much funding has BioTrack raised?

BioTrack has raised $5M in total.

Benchmark your own stack

Request an embedded finance strategy assessment

Get a read on where your own stack stands against BioTrack and the rest of its category — what they built versus bought, which providers they use, and where the gaps in your own strategy and competitive set actually are.

  • Your category, mappedHow your stack compares to BioTrack and the other companies in its category.
  • Build vs. buyWhere a provider relationship would close a gap faster than building it.
  • A named analyst, not a form replyA short call to scope what's actually worth assessing for you.

No newsletter, no sharing your address. We use this to reach out about the assessment and nothing else.